Publicaciones en colaboración con investigadores/as de University of Bonn (34)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

    Ophthalmology, Vol. 131, Núm. 8, pp. 914-926

2023

  1. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  2. Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

    Immunological Investigations, Vol. 52, Núm. 8, pp. 966-984

2022

  1. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    The Lancet, Vol. 399, Núm. 10326, pp. 729-740

  2. TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: An international performance evaluation study

    Journal of Clinical Pathology, Vol. 75, Núm. 6, pp. 416-421

2021

  1. An update on endotoxin neutralization strategies in Gram-negative bacterial infections

    Expert Review of Anti-Infective Therapy, Vol. 19, Núm. 4, pp. 495-517

  2. Anti-infective and anti-inflammatory mode of action of peptide 19-2.5

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-18

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

2019

  1. Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation

    American Journal of Transplantation, Vol. 19, Núm. 1, pp. 48-61

  2. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1864, Núm. 10, pp. 1503-1513

  3. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery

    British Journal of Anaesthesia, Vol. 122, Núm. 2, pp. 170-179

2018

  1. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

  2. Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 10, pp. 1721-1730

2017

  1. Vitamin D and age-related macular degeneration

    Nutrients, Vol. 9, Núm. 10

2016

  1. Omega-3 Fatty Acids and Age-Related Macular Degeneration

    Ophthalmic Research, Vol. 55, Núm. 2, pp. 62-69

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

  2. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  3. Interactions of poly (anhydride) nanoparticles with macrophages in light of their vaccine adjuvant properties

    International Journal of Pharmaceutics, Vol. 496, Núm. 2, pp. 922-930